Rebecca Shipley to Antibodies, Viral
This is a "connection" page, showing publications Rebecca Shipley has written about Antibodies, Viral.
Connection Strength
0.508
-
Shipley R, Wright E, Smith SP, Selden D, Fooks AR, Banyard AC. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus. Viruses. 2022 12 09; 14(12).
Score: 0.169
-
Shipley R, Wright E, Lean FZX, Selden D, Horton DL, Fooks AR, Banyard AC. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus. Viruses. 2021 05 20; 13(5).
Score: 0.151
-
James J, Rhodes S, Ross CS, Skinner P, Smith SP, Shipley R, Warren CJ, Goharriz H, McElhinney LM, Temperton N, Wright E, Fooks AR, Clark TW, Brookes SM, Brown IH, Banyard AC. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies. Viruses. 2021 04 20; 13(4).
Score: 0.151
-
Lean FZX, Lamers MM, Smith SP, Shipley R, Schipper D, Temperton N, Haagmans BL, Banyard AC, Bewley KR, Carroll MW, Brookes SM, Brown I, Nu?ez A. Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens. Sci Rep. 2020 12 14; 10(1):21894.
Score: 0.037